What if we could reprogram our own aging cells to fight diseases and
improve our health?
CellRep pioneers dynamic cell reprogramming without gene editing, revolutionizing how cell therapies work. Our AI-powered platform discovers and validates compounds that enhance cellular function, addressing three critical limitations in current CAR-T therapies: poor efficacy in solid tumors, lengthy manufacturing time, and prohibitive costs. We’re making personalized medicine truly scalable, starting with cancer treatments and soon expanding into longevity applications.
Our Approach
End-to-end pipeline from target discovery to preclinical validation of cell reprogramming strategies.
Cells are nature's supercomputers
A universe of opportunities holding the key to enhance our health.
Our Technology and Platform
We have developed an innovative approach to enhance T cell functionality by reprogramming these cells to a rejuvenated state and with improved therapeutic potential.
Our platform includes:
In vitro Screening
Every cell therapy product faces unique challenges during delivery. CellRep's discovery platform is tailored to identify the optimal intracellular targets and candidate compounds to enhance cell profiles and maximize therapy efficacy. CellRep's methodology identifies, tests, and protects molecules while defining customized best practices for each cell therapy manufacturer.
Meet our brilliant team
Our team is built of experienced immunologists, biochemists and bioinformatic engineers working together to deliver the best solutions to improve current and future cell therapies.
